Biomarker Discovery and Therapeutic Innovations in Genito-Urinary Cancer Management

9,102
Total downloads
44k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 21 Nov 2025

Evaluation of expression profiles of APOA4, CEACAM1, CD147, DJ-1/PARK7, Gamma-synuclein, S100A1, and Stathmin-1 in urothelial carcinomas using immunohistochemical assays

Naveed Sharif
Walayat Shah
Asif Ali
Taj Ali Khan
Umar Nishan
Hussah M. Alobaid
Sher Zaman Safi
Syed A. A. Rizv
Nawshad Muhammad

doi 10.3389/fonc.2025.1587558

752 views

CASE REPORT

Published on 06 Nov 2025

Combination therapy with toripalimab and lenvatinib in metastatic type 2 papillary renal cell carcinoma: a Case Report

Wende Wang
Minna Chen
Wenwu Xue
De Zeng

doi 10.3389/fimmu.2025.1591489

1,112 views

SYSTEMATIC REVIEW

Published on 03 Oct 2025

Prognostic value of lymphocyte to monocyte ratio for the patients with bladder cancer: a systematic review and meta-analysis

Qiang Ren
Yumin Li
Hankai Chen
Yirun Chen

doi 10.3389/fonc.2025.1601040

1,069 views

ORIGINAL RESEARCH

Published on 11 Sep 2025

Multi-omics dissection of fatty acid metabolism heterogeneity identifies PRDX1 as a prognostic marker in bladder cancer

Li Wang
Zhe Chang
Si-yu Chen
Jian-wei Yang
Kang-yu Wang
Kun-peng Li
Shun Wan
Shan hui Liu
Li Yang

doi 10.3389/fimmu.2025.1669822

1,864 views
1 citation

ORIGINAL RESEARCH

Published on 10 Sep 2025

Prognostic value and molecular mechanism of photodynamic therapy and apoptosis related gene FGFR1 in bladder cancer

Lei Wang
Yanchun Wang
Yanqing Wang
Zhengwei Wang
Guangzhou Cheng
Zhunan Xu
Xiaoqiang Liu

doi 10.3389/fonc.2025.1578695

1,304 views

CASE REPORT

Published on 05 Sep 2025

Case Report: The first account of primary myeloid sarcoma of the testis combined with ipsilateral epididymal epithelioid hemangioendothelioma

Xi Chen
Li Liu

doi 10.3389/fmed.2025.1590907

1,339 views

ORIGINAL RESEARCH

Published on 29 Aug 2025

Angiogenesis-related gene NID2 profiling and immune infiltration in bladder cancer: prognostic implications and immunotherapy response

Jinxia Cao
Wang Zheng

doi 10.3389/fimmu.2025.1615173

1,674 views

ORIGINAL RESEARCH

Published on 17 Jul 2025

PCP4 inhibits the progression of prostate cancer through Ca2+/CAMKK2/AMPK/AR pathway

Wenqiao Jia
Zeyuan Yu
Feifei Sun
Ping Liu
Bo Han

doi 10.3389/fimmu.2025.1616046

1,772 views

ORIGINAL RESEARCH

Published on 15 Jul 2025

Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer

Yuanqiao Zhao
Zhuo Xing
Yongqi Zhao
Haozhe Xu
Ruilin Liu
Tiejun Yang
Yinhuai Wang
Xuan Zhu

doi 10.3389/fimmu.2025.1585727

5,132 views

CASE REPORT

Published on 02 May 2025

Case Report: Clinical response of ensartinib for inflammatory myofibroblastic tumor of the urinary bladder with multiple metastases and TPM4-ALK fusion

Hongtao Ren
Qi Cheng
Xi Chen
Dianjing Sui
Zhiyi Zhang
Fei Chen

doi 10.3389/fonc.2025.1481602

1,217 views
1 citation

SYSTEMATIC REVIEW

Published on 17 Mar 2025

Prognostic and predictive value of pre-treatment blood-based inflammatory biomarkers in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Ádám Széles
András Kubik
Szilárd Váncsa
Viktor Grünwald
Boris Hadaschik
Nándor Ács
Péter Hegyi
Péter Nyirády
Tibor Szarvas

doi 10.3389/fimmu.2025.1554048

2,591 views
1 citation

MINI REVIEW

Published on 15 Jan 2025

Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy

David J. Benjamin
Robert C. Hsu

doi 10.3389/fonc.2024.1457006

2,721 views
5 citations

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Other participating journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.3 impact factor
- 6.9 citescore

Impact

44kTopic views
33kArticle views
9,102Article downloads

View impact

Articles

Evaluation of expression profiles of APOA4, CEACAM1, CD147, DJ-1/PARK7, Gamma-synuclein, S100A1, and Stathmin-1 in urothelial carcinomas using immunohistochemical assays

Combination therapy with toripalimab and lenvatinib in metastatic type 2 papillary renal cell carcinoma: a Case Report

Prognostic value of lymphocyte to monocyte ratio for the patients with bladder cancer: a systematic review and meta-analysis

Multi-omics dissection of fatty acid metabolism heterogeneity identifies PRDX1 as a prognostic marker in bladder cancer

Prognostic value and molecular mechanism of photodynamic therapy and apoptosis related gene FGFR1 in bladder cancer

Case Report: The first account of primary myeloid sarcoma of the testis combined with ipsilateral epididymal epithelioid hemangioendothelioma

Angiogenesis-related gene NID2 profiling and immune infiltration in bladder cancer: prognostic implications and immunotherapy response

PCP4 inhibits the progression of prostate cancer through Ca2+/CAMKK2/AMPK/AR pathway

Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer

Case Report: Clinical response of ensartinib for inflammatory myofibroblastic tumor of the urinary bladder with multiple metastases and TPM4-ALK fusion

Prognostic and predictive value of pre-treatment blood-based inflammatory biomarkers in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Other participating journals

Frontiers in Oncology

Cancer Immunity and Immunotherapy